reports
ParaZero Achieves Extraordinary Results in Intercepting High Speed Hos...
ParaZero Achieves Extraordinary Results in Intercepting High Speed Hostile Drones at High Speed of 70 mph Kfar Saba, Israel, Feb. 18, 2026 (GLOBE NEWSWIRE) -- ParaZero Technologies Ltd. (Nasdaq: PRZO) (the “company” or “ParaZero”), an aerospace defense company pioneering smart, autonomous solutions for the global manned and unmanned aerial systems (UAS) industry, proudly announces outstanding results from an internal live testing of its DefendAir™ system. In the trial, DefendAir successfully intercepted a fast-moving drone traveling at 70 mph using its patented net-launching technology...
Appili Therapeutics Announces Closing of Second Tranche of Non-Brokere...
Appili Therapeutics Announces Closing of Second Tranche of Non-Brokered Private Placement NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. WIRE SERVICES HALIFAX, Nova Scotia, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Appili Therapeutics Inc. (TSX: APLI; OTCPink: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, is pleased to announce that it has closed the second tranche of its previously announced non-brokered private placement for aggregate gross proceeds of C$100,000 (the “Priv...
Verisk Reports Fourth-Quarter and Full-Year 2025 Financial Results
Verisk Reports Fourth-Quarter and Full-Year 2025 Financial Results Fourth Quarter Highlights Revenue was $779 million, up 5.9%, and up 5.2% on an organic constant currency (OCC) basis, a non-GAAP measure.Net income was $197 million, down 6.2% due to gains recognized in the prior year.Adjusted EBITDA, a non-GAAP measure, was $437 million, up 9.8%, and up 6.2% on an OCC basis.Diluted GAAP earnings per share was $1.42, down 1.4%.Diluted adjusted EPS, a non-GAAP measure, was $1.82, up 13.0%.Net cash provided by operating activities was $343 million, up 34.4% and free cash flow, a non-GAAP meas...
- Blair Levin
Does the Trump/Kennedy Center Fiasco Portend PSKY's Future?
It now appears that PSKY has a good chance of prevailing in its battle for WBD. We have previously discussed the three phases of that battle; the proxy battle, the antitrust review, and the judicial review. In this note, we discuss a fourth phase; how does the battle for WBD, including this week’s Colbert/Talarico Affair, affect PSKY’s value after the deal closes?
Jeffs’ Brands: KeepZone AI Enters into Agreement to Sell Advanced AI T...
Jeffs’ Brands: KeepZone AI Enters into Agreement to Sell Advanced AI Threat Detection Solution in Mexico's Security Sector Targeting enhanced safety for FIFA World Cup 2026 in Mexico City through SeeTrue’s AI-powered automated threat detection technology Tel Aviv, Israel, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Jeffs' Brands Ltd (“Jeffs’ Brands” or the “Company”) (Nasdaq: JFBR, JFBRW), a data-driven e-commerce company operating on the Amazon Marketplace expanding into the global homeland security sector through advanced artificial intelligence (“AI”) – driven solutions, recently announced tha...
Tilray Brands and the Carlsberg Group Enter into an Exclusive Multi-Ye...
Tilray Brands and the Carlsberg Group Enter into an Exclusive Multi-Year U.S. Brewing and Commercial Partnership NEW YORK, Feb. 18, 2026 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (NASDAQ: TLRY; TSX: TLRY), a leading global consumer packaged goods company and the fourth-largest craft beer brewer in the United States, today announced that it has entered into an exclusive licensing agreement starting January 1, 2027 with the Carlsberg Group, one of the world’s premier brewing organizations and among the largest globally by revenue. Under the terms of the agreement, Tilray has been granted a m...
- James Ratzer
UKO Microshops AG: 1 director
A director at UKO Microshops AG sold 285,715 shares at 2.100EUR and the significance rating of the trade was 96/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clear...
Scorpio Tankers Inc: 1 director
A director at Scorpio Tankers Inc sold 5,000 shares at 70.510USD and the significance rating of the trade was 73/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clea...
Radware Ltd: 1 director
A director at Radware Ltd sold 13,750 shares at 26.390USD and the significance rating of the trade was 73/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sho...
Ocugen to Host Conference Call on Wednesday, March 4, 2026 at 8:30 A.M...
Ocugen to Host Conference Call on Wednesday, March 4, 2026 at 8:30 A.M. ET to Discuss Business Updates and Fourth Quarter and Full Year 2025 Financial Results MALVERN, Pa., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that it will host a conference call and live webcast to discuss the Company’s fourth quarter and full year 2025 financial results and provide a business update at 8:30 a.m. ET on Wednesday, March 4, 2026. Ocugen will issue a pre-market earnin...
Papiers Tissu KP déclare un dividende trimestriel de 0,18 $ par action...
Papiers Tissu KP déclare un dividende trimestriel de 0,18 $ par action ordinaire NON DESTINÉ À LA PUBLICATION AUX ÉTATS-UNIS NI AUX AGENCES DE TRANSMISSION AMÉRICAINES MISSISSAUGA, Ontario, 18 févr. 2026 (GLOBE NEWSWIRE) -- Papiers Tissu KP inc. (TSX : KPT) (PTKP) a annoncé aujourd’hui que son conseil d’administration a déclaré un dividende trimestriel de 0,18 $ par action ordinaire. Ce dividende sera payable le 15 avril 2026 aux actionnaires inscrits à la fermeture des bureaux le 31 mars 2026, sous réserve des lois applicables. Les dividendes versés pourront être considérés comme « ad...
Mister Car Wash Announces Fourth Quarter and Full Year 2025 Results
Mister Car Wash Announces Fourth Quarter and Full Year 2025 Results Net revenues increased 4%Comparable-store sales increased 1.6%Unlimited Wash Club® (“UWC”) memberships increased 7%Opened 16 new greenfield locations TUCSON, Ariz., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Mister Car Wash, Inc. (the “Company”) (Nasdaq: MCW), the nation’s leading car wash brand, today announced its financial results for the quarter and year ended December 31, 2025. “We delivered a strong finish to 2025, highlighted by solid membership growth of 7% in the fourth quarter to end the year with nearly 2.3 million me...
KP Tissue declares a Quarterly Dividend of $0.18 per Common Share
KP Tissue declares a Quarterly Dividend of $0.18 per Common Share NOT FOR DISTRIBUTION IN THE U.S.A. OR OVER U.S. WIRE SERVICES MISSISSAUGA, Ontario, Feb. 18, 2026 (GLOBE NEWSWIRE) -- KP Tissue Inc. (KPT) (TSX: KPT) announced today that the Board of Directors has declared a quarterly dividend of $0.18 per common share, payable on April 15, 2026, to shareholders of record at the close of business on March 31, 2026, subject to applicable law. The dividends paid are designated as "eligible" dividends for the purposes of the Income Tax Act (Canada) and any similar provincial and territorial...
EyePoint Appoints Michael Campbell as Chief Commercial Officer
EyePoint Appoints Michael Campbell as Chief Commercial Officer – Seasoned commercial executive with over 30 years of leadership in retinal disease across biotech and large pharma –– Brings established track record of successful product launches and oversight of prominent ophthalmology franchises, including Lucentis® and Xiidra® – WATERTOWN, Mass., Feb. 18, 2026 (GLOBE NEWSWIRE) -- EyePoint, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing innovative therapeutics to improve the lives of patients with serious retinal diseases, today announced that Michael Campbell...
KP Tissue Releases Fourth Quarter and Full Year 2025 Financial Results
KP Tissue Releases Fourth Quarter and Full Year 2025 Financial Results Strong financial and operational performance in 2025 MISSISSAUGA, Ontario, Feb. 18, 2026 (GLOBE NEWSWIRE) -- KP Tissue Inc. (KPT) (TSX: KPT) reports the Q4 2025 and full year 2025 financial and operational results of KPT and Kruger Products Inc. (Kruger Products). Kruger Products is Canada's leading manufacturer of quality tissue products for the Consumer market (Cashmere®, Purex®, SpongeTowels®, Scotties®, White Swan® and Bonterra®) and the Away-From-Home (AFH) market and continues to grow in the U.S. Consumer tissu...
Papiers Tissu KP publie ses résultats du quatrième trimestre et de l’e...
Papiers Tissu KP publie ses résultats du quatrième trimestre et de l’exercice 2025 Une solide performance financière et opérationnelle au cours de l’exercice 2025 MISSISSAUGA, Ontario, 18 févr. 2026 (GLOBE NEWSWIRE) -- Papiers Tissu KP inc. (« PTKP ») (TSX : KPT) présente ses résultats financiers et ses résultats d’exploitation, ainsi que ceux de Produits Kruger inc. (« Produits Kruger »), du quatrième trimestre et de l’exercice 2025. Produits Kruger est le premier fabricant canadien de produits de papier de qualité destinés aux consommateurs (CashmereMD, PurexMD, SpongeTowelsMD, Scotti...
NewAmsterdam Pharma Reports Full Year 2025 Financial Results and Provi...
NewAmsterdam Pharma Reports Full Year 2025 Financial Results and Provides Corporate Update -- Approval decisions from EMA, UK and Switzerland regulators for obicetrapib and obicetrapib/ezetimibe fixed dose combination expected in 2H26 -- -- Phase 3 PREVAIL CVOT blinded event rate tracking in line with observed event rate in BROADWAY-- -- Topline data from RUBENS Phase 3 trial in patients with type 2 diabetes and metabolic syndrome expected by year-end 2026 -- -- $728.9 million in cash, cash equivalents and marketable securities at December 31, 2025 -- NAARDEN, the Nethe...
Le secteur minier génère une hausse sans précédent de la capitalisatio...
Le classement annuel des sociétés les plus performantes inscrites à la Bourse de croissance TSX marque un tournant important vers le secteur des ressources, avec des rendements moyens de 431 % et plus de 1,5 milliard de dollars en nouveaux capitaux.Toronto, Ontario--(Newsfile Corp. - 18 février 2026) - La Bourse de croissance TSX (TSXV) a dévoilé aujourd'hui son palmarès TSX Venture 50 de 2026, qui dresse la liste des sociétés les plus performantes de 2025. La liste reflète l'année historique qu'ont connue les sociétés à petite capitalisation du secteur minier et du secteur des hautes technolo...
WEBUY GLOBAL LTD. Launches Premium Travel Brand “Altitude,” Drives aro...
WEBUY GLOBAL LTD. Launches Premium Travel Brand “Altitude,” Drives around US$400K in Opening Sales Singapore, Feb. 18, 2026 (GLOBE NEWSWIRE) -- WEBUY GLOBAL LTD. (Nasdaq: WBUY) (“Webuy” or the “Company”), a technology-driven travel and lifestyle platform, today announced the successful launch of Altitude, its new AI-powered premium travel advisory brand. Altitude officially held its grand opening on January 26, 2026. Following its launch, Altitude generated approximately US$400,000 in travel bookings, demonstrating early market demand for its next-generation, technology-enabled travel ex...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.